According to Life Healthcare Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 8.99977. At the end of 2022 the company had a P/E ratio of 15.6.
Year | P/E ratio | Change |
---|---|---|
2022 | 15.6 | -1.57% |
2021 | 15.9 | -106.91% |
2020 | -230 | -2337.42% |
2019 | 10.3 | -38% |
2018 | 16.6 | -39.28% |
2017 | 27.3 | 49.74% |
2016 | 18.2 | 19.03% |
2015 | 15.3 | 37.39% |
2014 | 11.1 | -15.2% |
2013 | 13.1 | 24.8% |
2012 | 10.5 | 47.14% |
2011 | 7.15 | -21.6% |
2010 | 9.12 | 107.11% |
2009 | 4.40 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.